The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.

@article{Bamias2006TheCO,
  title={The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.},
  author={Aristotelis Bamias and Lia Angela Moulopoulos and Aggelos Koutras and Gerassimos Aravantinos and George Fountzilas and Dimitrios G Pectasides and Efstathios Kastritis and Dimitros Gika and Dimosthenis Vasilios Skarlos and Helena Linardou and Haralambos P. Kalofonos and Meletios Athanasios Dimopoulos},
  journal={Cancer},
  year={2006},
  volume={106 2},
  pages={297-303}
}
BACKGROUND The toxicity of platinum-based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplatin-based treatment. The objective of the current multicenter Phase II study was to evaluate the safety and efficacy of the combination of gemcitabine and carboplatin as first-line treatment in unselected patients with… CONTINUE READING
27 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…